Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC NB-598 131060-14-5 10mg
SDP

Supplier:  Apexbio Technology LLC A364510

Encompass_Preferred

NB-598 is a selective inhibitor targeting squalene epoxidase (SE) an enzyme that catalyzes the conversion of squalene into 2 3-oxidosqualene a crucial intermediate step within the cholesterol biosynthesis pathway Through competitive inhibition of SE NB-598 interferes with the metabolic pathway associated with triglyceride synthesis involving downstream intermediates such as farnesol In experimental studies utilizing isolated murine pancreatic islets NB-598 inhibits insulin secretion under basal and glucose-stimulated conditions suggesting a functional relationship between SE activity and insulin release processes Additionally NB-598 exerts inhibitory effects on voltage-dependent calcium channels (CaV channels) pointing to a potential link between SE-mediated lipid metabolism and calcium-related cellular signaling in endocrine research This compound serves as a pharmacological tool in lipid metabolism diabetes and endocrine function studies

Catalog No. 50-000-63197


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.